Jobs at Revolution Medicines

Leads global pricing strategy and execution for an oncology biopharmaceutical portfolio. Establishes pricing architecture, launch and lifecycle strategies, contracting guardrails, financial models, governance, dashboards, and local execution frameworks. Partners across market access, commercial, medical, finance, legal, regulatory, supply chain, and regional teams. Supports launch readiness, executive decision-making, and development of a high-performing global pricing organization.

Leads global finance strategy and operating models for international market expansion. Oversees finance readiness, interim market leadership, controllership, accounting, reporting, SOX controls, governance, service providers, and transitions to local or outsourced teams. Partners with Accounting, SEC Reporting, Tax, Treasury, Legal, HR, FP&A, auditors, and executives to establish compliant, scalable processes across multiple jurisdictions.

Leads PDAC marketing strategy, brand planning, positioning, promotional and medical education initiatives for oncology product launches. Builds and manages a marketing team, develops strategic partnerships, collaborates with sales and field teams, engages healthcare stakeholders, manages budgets, and drives omnichannel growth. Requires extensive biotechnology or pharmaceutical commercial marketing experience, launch expertise, executive leadership, and strong cross-functional influence.

Leads Revolution Medicines’ corporate development strategy and organization, identifying, evaluating, negotiating, and executing partnerships, licensing agreements, acquisitions, collaborations, investments, and other strategic transactions. Advises executive leadership and the Board on portfolio strategy, valuation, transaction economics, and capital allocation. Builds cross-functional alignment, develops external relationships across the life sciences ecosystem, and recruits and leads a high-performing corporate development team.

Leads strategic biopharmaceutical transactions and partnering activities, including licensing, collaborations, co-development, alliances, options, and platform agreements. Oversees deal evaluation, structuring, negotiation, diligence, valuation, governance, executive and board recommendations, and closing. Builds relationships across biotechnology, pharmaceutical, academic, and investment communities while leading cross-functional teams. Recruits, develops, and manages a high-performing transactions and partnering organization, establishing scalable processes, governance, and operating practices aligned with corporate and portfolio priorities.

Provides full-cycle recruiting support for a biotechnology company, partnering with hiring leaders to develop recruiting strategies, source and assess candidates, manage interviews, negotiate offers, and support onboarding. Advises senior stakeholders with market insights and hiring recommendations, attracts passive talent, maintains ATS data, improves recruiting processes, and ensures a strong candidate experience across multiple concurrent searches.

Lead enterprise procurement at a clinical-stage biotechnology company. Build and execute procurement strategy, scale operating model, run strategic sourcing and supplier governance, drive procurement transformation, implement procurement systems and processes, oversee supplier risk/compliance, and mentor a growing procurement team to support R&D, clinical, manufacturing, commercial, IT, and corporate functions.

Manages global and domestic tax compliance and reporting, including VAT/GST, ASC 740 tax provisions, transfer pricing, income tax, sales and use tax, audits, tax credits, SEC disclosures, and SOX controls. Partners with internal finance teams and external advisors across multiple jurisdictions, supports international expansion, improves tax processes, and coordinates tax authority inquiries and documentation.

Develop and execute Germany’s government affairs strategy for a biotechnology company, representing the organization with policymakers, healthcare stakeholders, industry associations, and patient organizations. Monitor healthcare policy, advise leadership, prepare executive engagements, manage agencies and vendors, support budget allocation, and ensure compliance with regulatory and ethical standards. Collaborate cross-functionally with Communications, Medical Affairs, Market Access, and Patient Advocacy to advance patient-centered policy objectives and strengthen corporate reputation.

Leads market access, reimbursement, pricing, HTA submissions, value demonstration, payer negotiations, and launch readiness for oncology therapies across Belgium and Luxembourg. Develops country strategies, pricing and value-based contracting models, payer engagement plans, and evidence-based dossiers. Partners with medical, regulatory, commercial, and regional teams while monitoring policy developments and influencing European access strategy. Requires extensive BeLux market access experience, oncology launch expertise, and stakeholder leadership.

Leads Germany market access strategy for oncology therapies, including AMNOG and G-BA benefit assessments, pricing and reimbursement dossiers, payer negotiations, value communication, stakeholder engagement, policy monitoring, and launch readiness. Partners with global, regional, HEOR, medical affairs, and commercial teams to support sustainable patient access, pricing strategy, early access planning, and reimbursement outcomes.

Manages pharmaceutical revenue accounting and gross-to-net close activities, including reserves, reconciliations, journal entries, forecasting, reporting, audits, and SOX controls. Partners with Commercial, Market Access, FP&A, Analytics, Supply Chain, and external government pricing consultants to support launch readiness. Improves GTN forecasting, automation, AI-enabled accounting tools, documentation, and month-end close processes.

Leads Revolution Medicines’ Netherlands expansion, including country strategy, P&L, operations, team building, oncology product launches, market access, pricing, marketing, distributor management, governance, risk, and compliance. Requires extensive Netherlands biopharmaceutical leadership experience, oncology launch expertise, local market knowledge, and fluency in English and the local language.

Leads finance and operations for the JPAC region, overseeing strategic planning, budgeting, forecasting, P&L performance, accounting, treasury, procurement, controls, compliance, risk management, commercial launch readiness, affiliate expansion, distribution coordination, and operational infrastructure. Partners with executive and global functional leaders while building a high-performing regional organization and supporting international pharmaceutical commercialization.

Leads regional commercial strategy, market access, pricing, launch planning, new product planning, and commercial operations across the JPAC region. Partners with global and local functions to prepare oncology product launches, optimize reimbursement and patient access, improve forecasting and performance management, and translate global strategies into market-specific execution. Builds commercial capabilities across affiliates and distributors, represents regional priorities in global governance, and develops a high-performing commercial organization.

Supports portfolio planning, business operations, strategic decision-making, resource allocation, risk management, and execution across a life sciences organization. Leads portfolio reporting, metrics, dashboards, scenario modeling, budgeting, long-range planning, governance, and operational improvement initiatives. Facilitates cross-functional alignment, develops executive recommendations, and communicates complex insights to senior leadership. Requires strong analytical, project management, problem-solving, communication, and stakeholder-influence skills in a fast-paced environment.

Leads U.S. commercialization operations, strategic and financial planning, governance, launch readiness, executive communications, organizational effectiveness, change management, and cross-functional alignment. Partners with senior leaders across marketing, field, market access, medical affairs, finance, legal, analytics, and global commercial operations. Builds scalable processes, dashboards, capabilities, and high-performing teams while ensuring compliant commercialization and fostering organizational culture.

Lead Switzerland commercial strategy and execution for Revolution Medicines oncology portfolio. Build and manage the country commercial organization, drive launch readiness and market access alignment, translate clinical and economic evidence into local value messaging, oversee forecasting and performance, and ensure effective stakeholder engagement with HCPs, payers, and treatment centers. Coordinate cross-functionally with Medical Affairs, Market Access, and European teams; monitor market dynamics; and support national and international travel as required.

Leads global supply chain planning for late-stage clinical and commercial pharmaceutical programs. Owns S&OP and D&OP, demand and supply balancing, inventory and capacity strategies, launch readiness, risk mitigation, supply network resilience, planning systems, ERP integration, master data governance, and cross-functional alignment across clinical, commercial, manufacturing, quality, and regulatory teams. Builds scalable planning capabilities to ensure reliable worldwide delivery of small molecule drug substance, drug product, packaging, and labeling.

Provides pharmacovigilance and medical safety oversight across clinical development programs. Responsibilities include surveillance of clinical trials, medical review of safety reports, signal detection, benefit-risk assessment, risk mitigation, safety document authoring and review, regulatory filing support, safety data presentation, and collaboration with internal and external stakeholders.